hERG Screening Market (Type: Gene KCNH2 and Mutant KCNH2; and Ion Channel: Voltage-Gated and Ligand-Gated) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

hERG Screening Market (Type: Gene KCNH2 and Mutant KCNH2; and Ion Channel: Voltage-Gated and Ligand-Gated) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


hERG Screening Market – Scope of Report

TMR’s report on the global hERG screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hERG screening market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hERG screening market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hERG screening market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hERG screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hERG screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hERG screening market.

The report delves into the competitive landscape of the global hERG screening market. Key players operating in the global hERG screening market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hERG screening market profiled in this report.

Key Questions Answered in Global hERG screening Market Report
  • What is the sales/revenue generated by hERG screening across all regions during the forecast period?
  • What are the opportunities in the global hERG screening market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
hERG Screening Market – Research Objectives and Research Approach

The comprehensive report on the global hERG screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hERG screening market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hERG screening market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: hERG Screening Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. HERG Screening Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global hERG Screening Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. Gene KCNH2
6.3.2. Mutant KCNH2
6.4. Market Attractiveness Analysis, by Type
7. Global hERG Screening Market Analysis and Forecast, by Ion Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Ion Channel, 2020-2034
7.3.1. Voltage-Gated
7.3.2. Ligand-Gated
7.4. Market Attractiveness Analysis, by Ion Channel
8. Global hERG Screening Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Antiarrhythmic
8.3.2. Antipsychotic
8.3.3. Antibiotics
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global hERG Screening Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America hERG Screening Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. Gene KCNH2
10.3.2. Mutant KCNH2
10.4. Market Value Forecast, by Ion Channel, 2020-2034
10.4.1. Voltage-Gated
10.4.2. Ligand-Gated
10.5. Market Value Forecast, by Application, 2020-2034
10.5.1. Antiarrhythmic
10.5.2. Antipsychotic
10.5.3. Antibiotics
10.5.4. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Ion Channel
10.7.3. By Application
10.7.4. By Country
11. Europe hERG Screening Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. Gene KCNH2
11.3.2. Mutant KCNH2
11.4. Market Value Forecast, by Ion Channel, 2020-2034
11.4.1. Voltage-Gated
11.4.2. Ligand-Gated
11.5. Market Value Forecast, by Application, 2020-2034
11.5.1. Antiarrhythmic
11.5.2. Antipsychotic
11.5.3. Antibiotics
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Ion Channel
11.7.3. By Application
11.7.4. By Country/Sub-region
12. Asia Pacific hERG Screening Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. Gene KCNH2
12.3.2. Mutant KCNH2
12.4. Market Value Forecast, by Ion Channel, 2020-2034
12.4.1. Voltage-Gated
12.4.2. Ligand-Gated
12.5. Market Value Forecast, by Application, 2020-2034
12.5.1. Antiarrhythmic
12.5.2. Antipsychotic
12.5.3. Antibiotics
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Ion Channel
12.7.3. By Application
12.7.4. By Country/Sub-region
13. Latin America hERG Screening Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. Gene KCNH2
13.3.2. Mutant KCNH2
13.4. Market Value Forecast, by Ion Channel, 2020-2034
13.4.1. Voltage-Gated
13.4.2. Ligand-Gated
13.5. Market Value Forecast, by Application, 2020-2034
13.5.1. Antiarrhythmic
13.5.2. Antipsychotic
13.5.3. Antibiotics
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Ion Channel
13.7.3. By Application
13.7.4. By Country/Sub-region
14. Middle East & Africa hERG Screening Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. Gene KCNH2
14.3.2. Mutant KCNH2
14.4. Market Value Forecast, by Ion Channel, 2020-2034
14.4.1. Voltage-Gated
14.4.2. Ligand-Gated
14.5. Market Value Forecast, by Application, 2020-2034
14.5.1. Antiarrhythmic
14.5.2. Antipsychotic
14.5.3. Antibiotics
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Ion Channel
14.7.3. By Application
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Abcam Limited
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. ABR-Affinity BioReagents, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. AstraZeneca plc
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Aureus Sciences
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. AVIVA Biosciences
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Cambridge Biosciences
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. ChanTest Corporation
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Charles River Laboratories
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Chemaxon
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings